Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation

被引:13
|
作者
Hjerpe, Roland [1 ]
Aillet, Fabienne [1 ]
Lopitz-Otsoa, Fernando [1 ]
Lang, Valerie [1 ]
Torres-Ramos, Monica [1 ]
Farras, Rosa [3 ]
Hay, Ronald T. [4 ]
Rodriguez, Manuel S. [1 ,2 ]
机构
[1] CIC bioGUNE, Prote Unit, CIBERehd, Derio 48160, Bizkaia, Spain
[2] Univ Basque Country, Dept Biochem, Leioa 48940, Bizkaia, Spain
[3] Ctr Invest Principe Felipe, Valencia 46013, Spain
[4] Univ Dundee, Sch Life Sci, Interdisciplinary Res Ctr, Dundee DD1 5EH, Scotland
关键词
p53; Polyubiquitylation; Degradation; Mdm2; Proteasome; TERMINAL DOMAIN; TRANSCRIPTIONAL ACTIVITY; PROTEIN-DEGRADATION; ACTIVATE P53; IN-VIVO; UBIQUITINATION; MDM2; MULTIPLE; IDENTIFICATION; MUTATIONS;
D O I
10.1016/j.biocel.2010.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In normal cells p53 is maintained at low level through the action of the ubiquitin-proteasome system. As a consequence of p53 transcriptional activity, various regulators of this tumor suppressor are produced, forming a negative feedback loop tightly controlling p53 stability. One of the most prominent is the ubiquitin-ligase Mdm2. Here, we have used a transfer of signals strategy to study the p53 degradation process promoted by Mdm2 in the absence of p53 transcriptional activity. Our results show that in a p53 null background, transcriptionally silent p53-fusions require multiple N- and C-terminal signals to be optimally targeted to proteasomal degradation. As for WT p53, p53-fusions able to form tetramers are polyubiquitylated and optimally degraded by the proteasome. However, p53 molecules unable to oligomerize, show Mdm2-mediated polyubiquitylation deficiency but are still targeted to proteasome degradation in vitro and ex vivo. In the presence of Mdm2, nuclear shuttling of p53 monomeric fusions favours proteasome-dependent degradability but not its polyubiquitylation. In vitro, 265 proteasome fails to drive degradation of OD mutants in the presence of Mdm2, suggesting the contribution of additional cellular factors in this process. All together, our results indicate that Mdm2-mediated proteasome-dependent degradation of polyubiquitylation deficient p53 monomers is mechanistically possible, taking alternative pathways to better achieve their proteolysis. These results support the existence of additional levels to regulate p53 stability and activity acting on individual subunits of the functional tetramer. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:725 / 735
页数:11
相关论文
共 50 条
  • [1] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [2] Mdm2-mediated ubiquitylation: p53 and beyond
    Marine, J-C
    Lozano, G.
    CELL DEATH AND DIFFERENTIATION, 2010, 17 (01) : 93 - 102
  • [3] Bre Enhances Osteoblastic Differentiation by Promoting the Mdm2-Mediated Degradation of p53
    Jin, Fujun
    Wang, Yiliang
    Wang, Xiaojing
    Wu, Yanting
    Wang, Xiaoyan
    Liu, Qiuying
    Zhu, Yexuan
    Liu, Enqi
    Fan, Jianglin
    Wang, Yifei
    STEM CELLS, 2017, 35 (07) : 1760 - 1772
  • [4] TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation
    Bae, Seunghee
    Jung, Jin Hyuk
    Kim, Karam
    An, In-Sook
    Kim, Soo-Yeon
    Lee, Jae Ho
    Park, In-Chul
    Jin, Young-Woo
    Lee, Su-Jae
    An, Sungkwan
    FEBS LETTERS, 2012, 586 (19) : 3057 - 3063
  • [5] Mdm2-mediated ubiquitylation: p53 and beyond
    J-C Marine
    G Lozano
    Cell Death & Differentiation, 2010, 17 : 93 - 102
  • [6] XPC promotes MDM2-mediated degradation of the p53 tumor suppressor
    Krzeszinski, Jing Yan
    Choe, Vitnary
    Shao, Jia
    Bao, Xin
    Cheng, Haili
    Luo, Shiwen
    Huo, Keke
    Rao, Hai
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (02) : 213 - 221
  • [7] UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation
    Wu, Hong
    Leng, Roger P.
    CELL CYCLE, 2011, 10 (12) : 1912 - 1915
  • [8] PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination
    Jin, Min
    Park, Seon-Joo
    Kim, Seok Won
    Kim, Hye Rim
    Hyun, Jin Won
    Lee, Jung-Hee
    BIOMOLECULES & THERAPEUTICS, 2017, 25 (04) : 396 - 403
  • [9] Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination
    Wei, Jinlian
    Yang, Yingrui
    Lu, Mengchen
    Xu, Lili
    Liu, Fang
    Yuan, Zhenwei
    Bao, Qichao
    Jiang, Zhengyu
    Xu, Xiaoli
    Guo, Xiaoke
    Zhang, Xiaojin
    You, Qidong
    Sun, Haopeng
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (02) : 174 - 189
  • [10] Controlled Access of p53 to the Nucleus Regulates Its Proteasomal Degradation by MDM2
    Davis, James R.
    Mossalam, Mohanad
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2013, 10 (04) : 1340 - 1349